NCT01412203 - Clinical Trial References

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Citation(s)

Naylor PJ, Macdonald HM, Reed KE, McKay HA
Action Schools! BC: a socioecological approach to modifying chronic disease risk factors in elementary school children. Prev Chronic Dis. 2006 Apr;3(2):A60. Epub 2006 Mar 15.
Naylor PJ, Macdonald HM, Zebedee JA, Reed KE, McKay HA
Lessons learned from Action Schools! BC--an 'active school' model to promote physical activity in elementary schools. J Sci Med Sport. 2006 Oct;9(5):413-23. Epub 2006 Aug 1.

Evaluating the Effectiveness of the Dissemination of Action Schools! BC: A Socio-ecological Intervention to Increase Physical Activity and Healthy Eating in School Children

Details for clinical trial NCT01412203

Clinical trial NCT01412203 - References